Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

The Design of an Energy Harvesting Wireless Sensor Node for Tracking Pink Iguanas.

Loreti P, Catini A, De Luca M, Bracciale L, Gentile G, Di Natale C.

Sensors (Basel). 2019 Feb 26;19(5). pii: E985. doi: 10.3390/s19050985.

2.

Mitochondrial DNA haplogroups and incidence of lipodystrophy in HIV-infected patients on long-term antiretroviral therapy.

De Luca A, Nasi M, Di Giambenedetto S, Cozzi-Lepri A, Pinti M, Marzocchetti A, Mussini C, Fabbiani M, Bracciale L, Cauda R, Cossarizza A.

J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):113-20. doi: 10.1097/QAI.0b013e31823daff3..

PMID:
22245716
3.

Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure.

Fabbiani M, Bracciale L, Ragazzoni E, Santangelo R, Cattani P, Di Giambenedetto S, Fadda G, Navarra P, Cauda R, De Luca A.

Infection. 2011 Dec;39(6):563-9. doi: 10.1007/s15010-011-0183-8. Epub 2011 Aug 25.

PMID:
21866336
4.

The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy.

Marzocchetti A, Schwarz J, Di Giambenedetto S, Colafigli M, Bracciale L, Fabbiani M, Fantoni M, Trecarichi E, Cauda R, De Luca A.

AIDS Res Hum Retroviruses. 2011 Dec;27(12):1299-309. doi: 10.1089/aid.2010.0172. Epub 2011 Jun 20.

PMID:
21595566
5.

Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.

Ciccarelli N, Fabbiani M, Di Giambenedetto S, Fanti I, Baldonero E, Bracciale L, Tamburrini E, Cauda R, De Luca A, Silveri MC.

Neurology. 2011 Apr 19;76(16):1403-9. doi: 10.1212/WNL.0b013e31821670fb.

PMID:
21502598
6.

Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients.

Fabbiani M, Bracciale L, Doino M, D'Avino A, Marzocchetti A, Navarra P, Cauda R, De Luca A, Di Giambenedetto S.

J Infect. 2011 Apr;62(4):319-21. doi: 10.1016/j.jinf.2011.02.004. Epub 2011 Feb 15. No abstract available.

PMID:
21329725
7.

Lipid-lowering effect of tenofovir in HIV-infected patients.

Fabbiani M, Bracciale L, Doino M, Sidella L, Farina S, Di Cristo V, Cauda R, De Luca A, Di Giambenedetto S.

J Antimicrob Chemother. 2011 Mar;66(3):682-3. doi: 10.1093/jac/dkq464. Epub 2010 Dec 5. No abstract available.

PMID:
21131692
8.

Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction.

Fabbiani M, Di Giambenedetto S, Ragazzoni E, D'Ettorre G, Parruti G, Prosperi M, Bracciale L, Cauda R, Navarra P, De Luca A.

Pharmacol Res. 2011 Mar;63(3):249-53. doi: 10.1016/j.phrs.2010.11.009. Epub 2010 Dec 2.

PMID:
21130167
9.

The threshold bootstrap clustering: a new approach to find families or transmission clusters within molecular quasispecies.

Prosperi MC, De Luca A, Di Giambenedetto S, Bracciale L, Fabbiani M, Cauda R, Salemi M.

PLoS One. 2010 Oct 25;5(10):e13619. doi: 10.1371/journal.pone.0013619.

10.

Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping.

Prosperi MC, Bracciale L, Fabbiani M, Di Giambenedetto S, Razzolini F, Meini G, Colafigli M, Marzocchetti A, Cauda R, Zazzi M, De Luca A.

Retrovirology. 2010 Jun 30;7:56. doi: 10.1186/1742-4690-7-56.

11.

Resistance considerations in sequencing of antiretroviral therapy in low-middle income countries with currently available options.

De Luca A, Prosperi M, Bracciale L.

Curr Opin HIV AIDS. 2010 Jan;5(1):27-37. doi: 10.1097/COH.0b013e328333ad45. Review.

PMID:
20046145
12.

Predictors of successful genotype-guided antiretroviral therapy in treatment-experienced individuals over calendar years: a cohort study.

Bracciale L, Fanti I, Di Giambenedetto S, Colafigli M, Prosperi M, Bacarelli A, Santangelo R, Cattani P, Cauda R, De Luca A.

J Clin Virol. 2009 Nov;46(3):290-4. doi: 10.1016/j.jcv.2009.07.013. Epub 2009 Aug 21.

PMID:
19699675
13.

Impact of hepatitis B vaccination in children born to HBsAg-positive mothers: a 20-year retrospective study.

Bracciale L, Fabbiani M, Sansoni A, Luzzi L, Bernini L, Zanelli G.

Infection. 2009 Aug;37(4):340-3. doi: 10.1007/s15010-008-8252-3. Epub 2009 Jul 23.

PMID:
19629385
14.

Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.

Bracciale L, Colafigli M, Zazzi M, Corsi P, Meraviglia P, Micheli V, Maserati R, Gianotti N, Penco G, Setti M, Di Giambenedetto S, Butini L, Vivarelli A, Trezzi M, De Luca A.

J Antimicrob Chemother. 2009 Sep;64(3):607-15. doi: 10.1093/jac/dkp246. Epub 2009 Jul 16.

PMID:
19608581
15.

Long-term follow-up of nevirapine-treated patients in a single-centre cohort.

Colafigli M, Di Giambenedetto S, Bracciale L, Fanti I, Prosperi M, Cauda R, De Luca A.

HIV Med. 2009 Sep;10(8):461-9. doi: 10.1111/j.1468-1293.2009.00713.x. Epub 2009 May 6.

16.

Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice.

Fabbiani M, Di Giambenedetto S, Bracciale L, Bacarelli A, Ragazzoni E, Cauda R, Navarra P, De Luca A.

J Antimicrob Chemother. 2009 Jul;64(1):109-17. doi: 10.1093/jac/dkp132. Epub 2009 Apr 27.

PMID:
19398461
17.

Are mutations in HIV type-1 reverse transcriptase 245 codon predictive of abacavir hypersensitivity reaction?

Bracciale L, Santangelo R, Fanti I, Prosperi M, Colafigli M, Di Giambenedetto S, Marchetti S, Di Franco A, Cauda R, De Luca A.

Antivir Ther. 2009;14(1):99-101.

PMID:
19320242
18.

Virological suppression reduces clinical progression in patients with multiclass-resistant HIV type 1.

Bracciale L, Di Giambenedetto S, Colafigli M, La Torre G, Prosperi M, Santangelo R, Marchetti S, Cauda R, Fadda G, De Luca A.

AIDS Res Hum Retroviruses. 2009 Mar;25(3):261-7. doi: 10.1089/aid.2008.0136.

PMID:
19292594
19.

Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania.

Pippi F, Bracciale L, Stolzuoli L, Giaccherini R, Montomoli E, Gentile C, Filetti S, De Luca A, Cellesi C.

HIV Med. 2008 Aug;9(7):519-25. doi: 10.1111/j.1468-1293.2008.00598.x. Epub 2008 Jun 28.

20.

Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen.

Colafigli M, Di Giambenedetto S, Bracciale L, Tamburrini E, Cauda R, De Luca A.

HIV Med. 2008 Mar;9(3):172-9. doi: 10.1111/j.1468-1293.2007.00541.x. Epub 2008 Jan 21.

21.

Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study.

Di Giambenedetto S, Bracciale L, Colafigli M, Cattani P, Pinnetti C, Bacarelli A, Prosperi M, Fadda G, Cauda R, De Luca A.

Antivir Ther. 2007;12(5):835-9. Erratum in: Antivir Ther. 2007;12(7):1145. Colatigli, Manuela [corrected to Colafigli, Manuela; Cattani, Paola [added]; Pannetti, Carmen [corrected to Pinnetti, Carmen].

PMID:
17713168

Supplemental Content

Loading ...
Support Center